pharmacie et médicaments – Accès aux traitements innovants pour les maladies rares

This written question concerns access to innovative treatments for rare diseases. It seeks to understand the current situation and potential improvements in ensuring patients with rare conditions can access new therapies. The question is addressed to the government and aims to shed light on policies affecting patients, pharmaceutical companies, and healthcare providers involved in rare disease treatment.